BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 18824606)

  • 1. In vitro activity of the antifungal plant defensin RsAFP2 against Candida isolates and its in vivo efficacy in prophylactic murine models of candidiasis.
    Tavares PM; Thevissen K; Cammue BP; François IE; Barreto-Bergter E; Taborda CP; Marques AF; Rodrigues ML; Nimrichter L
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4522-5. PubMed ID: 18824606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antifungal activity of RsAFP2, a plant defensin from raphanus sativus, involves the induction of reactive oxygen species in Candida albicans.
    Aerts AM; François IE; Meert EM; Li QT; Cammue BP; Thevissen K
    J Mol Microbiol Biotechnol; 2007; 13(4):243-7. PubMed ID: 17827975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defensins from insects and plants interact with fungal glucosylceramides.
    Thevissen K; Warnecke DC; François IE; Leipelt M; Heinz E; Ott C; Zähringer U; Thomma BP; Ferket KK; Cammue BP
    J Biol Chem; 2004 Feb; 279(6):3900-5. PubMed ID: 14604982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The radish defensins RsAFP1 and RsAFP2 act synergistically with caspofungin against Candida albicans biofilms.
    Vriens K; Cools TL; Harvey PJ; Craik DJ; Braem A; Vleugels J; De Coninck B; Cammue BP; Thevissen K
    Peptides; 2016 Jan; 75():71-9. PubMed ID: 26592804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antifungal plant defensin RsAFP2 from radish induces apoptosis in a metacaspase independent way in Candida albicans.
    Aerts AM; Carmona-Gutierrez D; Lefevre S; Govaert G; François IE; Madeo F; Santos R; Cammue BP; Thevissen K
    FEBS Lett; 2009 Aug; 583(15):2513-6. PubMed ID: 19596007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The plant defensin RsAFP2 induces cell wall stress, septin mislocalization and accumulation of ceramides in Candida albicans.
    Thevissen K; de Mello Tavares P; Xu D; Blankenship J; Vandenbosch D; Idkowiak-Baldys J; Govaert G; Bink A; Rozental S; de Groot PW; Davis TR; Kumamoto CA; Vargas G; Nimrichter L; Coenye T; Mitchell A; Roemer T; Hannun YA; Cammue BP
    Mol Microbiol; 2012 Apr; 84(1):166-80. PubMed ID: 22384976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fungicidal Potency and Mechanisms of θ-Defensins against Multidrug-Resistant Candida Species.
    Basso V; Garcia A; Tran DQ; Schaal JB; Tran P; Ngole D; Aqeel Y; Tongaonkar P; Ouellette AJ; Selsted ME
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans.
    Jin J; Guo N; Zhang J; Ding Y; Tang X; Liang J; Li L; Deng X; Yu L
    Lett Appl Microbiol; 2010 Sep; 51(3):351-7. PubMed ID: 20681969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the antifungal activity of herbal toothpastes against other brands of toothpastes on clinical isolates of Candida albicans and Candida dubliniensis.
    Ellepola AN; Khan ZU; Chandy R; Philip L
    Med Princ Pract; 2011; 20(2):112-7. PubMed ID: 21252563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
    Maninder J; Usha A
    J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis.
    Spreghini E; Orlando F; Tavanti A; Senesi S; Giannini D; Manso E; Barchiesi F
    J Antimicrob Chemother; 2012 Sep; 67(9):2195-202. PubMed ID: 22635526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
    Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
    Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psd1 binding affinity toward fungal membrane components as assessed by SPR: The role of glucosylceramide in fungal recognition and entry.
    de Medeiros LN; Domitrovic T; de Andrade PC; Faria J; Bergter EB; Weissmüller G; Kurtenbach E
    Biopolymers; 2014 Nov; 102(6):456-64. PubMed ID: 25283273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of voriconazole against Candida species isolated in Taiwan.
    Yang YL; Cheng HH; Lo HJ
    Int J Antimicrob Agents; 2004 Sep; 24(3):294-6. PubMed ID: 15325436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis.
    Pinto PM; Weikert-Oliveira Rde C; Lyon JP; Cury VF; Arantes RR; Koga-Ito CY; Resende MA
    Microbiol Res; 2008; 163(5):579-85. PubMed ID: 16962755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infections due to Candida haemulonii: species identification, antifungal susceptibility and outcomes.
    Ruan SY; Kuo YW; Huang CT; Hsiue HC; Hsueh PR
    Int J Antimicrob Agents; 2010 Jan; 35(1):85-8. PubMed ID: 19786341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
    J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal curcumin induces reactive oxygen species and triggers an early apoptosis but prevents hyphae development by targeting the global repressor TUP1 in Candida albicans.
    Sharma M; Manoharlal R; Puri N; Prasad R
    Biosci Rep; 2010 Dec; 30(6):391-404. PubMed ID: 20017731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro interactions of anidulafungin with azole antifungals, amphotericin B and 5-fluorocytosine against Candida species.
    Karlowsky JA; Hoban DJ; Zhanel GG; Goldstein BP
    Int J Antimicrob Agents; 2006 Feb; 27(2):174-7. PubMed ID: 16414247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
    Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.